Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
22 June, 2026
Novel lung cancer radiation therapy approach to be tested in new PRIME-Lung trial
LATEST NEWS: 22 June 2026 In an important step
17 June, 2026
TROG Facility Alliance Member in Focus: Radiation Oncology Network, Western Sydney Local Health District
TROG’s Facility Alliance Members (FAM) are the cornerstone of